Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin’s lymphoma patients
暂无分享,去创建一个
P. Mazza | V. Pavone | G. Specchia | A. Carella | D. Pastore | G. Pisapia | M. Delia | N. Cascavilla | A. Mele | F. Gaudio | G. Palazzo